Compare XMTR & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XMTR | ITGR |
|---|---|---|
| Founded | 2013 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2021 | 2000 |
| Metric | XMTR | ITGR |
|---|---|---|
| Price | $55.66 | $86.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | $58.60 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 539.2K | 464.7K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.95 | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | $686,631,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | $23.76 | $1.69 |
| Revenue Next Year | $18.38 | $6.53 |
| P/E Ratio | ★ N/A | $176.60 |
| Revenue Growth | ★ 25.87 | 7.98 |
| 52 Week Low | $29.60 | $62.00 |
| 52 Week High | $73.87 | $123.78 |
| Indicator | XMTR | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 67.98 | 50.55 |
| Support Level | $55.13 | $82.58 |
| Resistance Level | $58.03 | $89.04 |
| Average True Range (ATR) | 2.79 | 3.70 |
| MACD | 0.92 | -0.21 |
| Stochastic Oscillator | 97.42 | 64.91 |
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.